Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

After a long, stressful day at work, or when pressed for time, the temptation to have a quick, satisfying snack—like crisps ...

Kids are more likely to maintain a healthy weight if their parents adopt a responsive style while they're babies and toddlers ...

Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...

The administration is reviewing a Centers for Medicare and Medicaid Services rule that would expand coverage to Medicare and Medicaid recipients ...

A Polish health survey found that being married increased risk of overweight in women and men, with the latter group also experiencing three times the risk of obesity.

Research published in Nature determined why obese individuals who lose weight tend to regain the weight over time. Here's how ...

Obesity has long been classified as a global epidemic — and new data published in The Lancet journal spotlights how much ...

The Maryland-based biopharma joins Eli Lilly and Novo Nordisk in trialing a GLP-1 agonist for alcohol- and liver-related ...

Professor Arne Astrup is also involved in project to change widely-accepted definition of ultra-processed food ...